Edaravone, a new therapeutic option in amyotrophic lateral sclerosis: Evaluation of challenges in the drug accessibility
1 |
Department of Pharmacology and Toxicology, Faculty of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, Poland |
2 |
Department of Psychology and Sociology of Health and Public Health, Collegium Medicum, University of Warmia and Mazury in Olsztyn, Poland |
3 |
Department of Neurology, Faculty of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, Poland |
CORRESPONDING AUTHOR
Łukasz Puchała
Department of Pharmacology and Toxicology, School of Medicine, Collegium
Medicum, University of Warmia and Mazury in Olsztyn, Warszawska 30, 10-028 Olsztyn, Poland. Tel.: +48 508 550 544
Submission date: 2019-11-21
Final revision date: 2020-07-20
Acceptance date: 2020-07-20
Online publication date: 2020-08-06
Pol. Ann. Med. 2020;27(2):220–224